Greenberg Traurig, LLP
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
The disclosure provides compositions comprising novel adenosine base editors (e.g., ABE8) that have increased efficiency and methods of using these adenosine deaminase variants for editing a target sequence.
BEAM THERAPEUTICS INC.
C A C C C C C C C C C C C
C07K A61P C12N C12N C12N C12N C12N C12N C12Y C12N C12N C07K C12Y
additional inventional inventional inventional additional additional inventional inventional inventional inventional inventional additional additional
Jason Michael Natalie David A. Bernd Yi Francine Ian Angelica Yvonne Seung-Joo Genesis Shaunna Nicole Michael
Gehrke Petrossian Born Zetsche Yu Gregoire Slaymaker Messana Aratyn Lee Lung Berkovitch Gaudelli Packer